归创通桥(02190)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02190 归创通桥

未开盘 03-31 16:08:25

23.240

-0.580

-2.43%

最高24.100	最低22.900	成交量47.15万
今开24.000	昨收23.820	日振幅5.04%
总市值78.32亿	流通市值76.69亿	总股本3.37亿
成交额1,103万	换手率0.14%	流通股本3.30亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02190","market":"HK","secType":"STK","nameCN":"归创通桥","latestPrice":23.24,"timestamp":1774944505005,"preClose":23.82,"halted":0,"volume":471509,"delay":0,"changeRate":-0.024349286314021907,"floatShares":330000000,"shares":337000000,"eps":0.8595241443108232,"marketStatus":"未开盘","change":-0.58,"latestTime":"03-31 16:08:25","open":24,"high":24.1,"low":22.9,"amount":11029386,"amplitude":0.050378,"askPrice":23.24,"askSize":6500,"bidPrice":23.16,"bidSize":500,"shortable":3,"etf":0,"ttmEps":0.8595241443108232,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1775007000000},"marketStatusCode":0,"adr":0,"listingDate":1625414400000,"exchange":"SEHK","adjPreClose":23.82,"dividendRate":0.010745,"openAndCloseTimeList":[[1774920600000,1774929600000],[1774933200000,1774944000000]],"volumeRatio":0.7153655152807987,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02190","defaultTab":"news","newsList":[{"id":"1154648116","title":"归创通桥回购4.75万股股份，耗资约110.78万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1154648116","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154648116?lang=zh_cn&edition=full","pubTime":"2026-03-31 19:33","pubTimestamp":1774956818,"startTime":"0","endTime":"0","summary":"归创通桥医疗科技股份有限公司（股票代码：02190）于2026年3月31日发布公告。公司当日在香港联交所场内回购股份，涉及数量为47,500股，占当时已发行股本约0.0141%。本次回购的每股价格介乎每股港币22.96元至24.10元之间，合计耗资约港币110.78万元。\n回购完成后，公司已发行股份数量变动为328,800,613股，库存股数量增至7,550,131股，总股本维持336,350,744股。公司回购授权于2025年5月30日获得通过，本次回购符合香港联交所上市规则及相关法律规定。\n本公告由公司董事赵中签署。公司确认本次回购事项已严格遵循所有适用的上市规则及监管要求。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02190"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105641324","title":"归创通桥：3月30日回购4.8万股，涉资约113.73万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1105641324","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1105641324?lang=zh_cn&edition=full","pubTime":"2026-03-30 20:25","pubTimestamp":1774873554,"startTime":"0","endTime":"0","summary":"归创通桥医疗科技股份有限公司于2026年3月30日发布公告，披露当日于香港联交所场内回购股份的情况。此次回购占公司已发行股本约0.0143%，每股回购价介乎每股23.32港元至23.82港元，累计动用资金1,137,290港元，折合约113.73万港元。回购完成后，公司已发行股本变动至328,848,113股，库藏股数增至7,502,631股。公告显示，公司于2025年5月30日通过股份购回授权，截至本次回购后仍有31,958,111股的购回额度。公司确认，该回购行为已经遵守香港联交所上市规则和相关法律规定。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02190"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623317007","title":"归创通桥(02190)3月30日耗资约113.73万港元回购4.8万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2623317007","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623317007?lang=zh_cn&edition=full","pubTime":"2026-03-30 20:25","pubTimestamp":1774873551,"startTime":"0","endTime":"0","summary":"智通财经APP讯，归创通桥(02190)公布，2026年3月30日耗资约113.73万港元回购4.8万股股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1422047.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","02190","BK1583","BK1100","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186038112","title":"归创通桥回购15万股股份，涉资约358.78万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1186038112","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186038112?lang=zh_cn&edition=full","pubTime":"2026-03-27 18:06","pubTimestamp":1774605966,"startTime":"0","endTime":"0","summary":"归创通桥医疗科技股份有限公司（股票代码：02190）于2026年3月27日公告，董事会批准并实施了股份回购措施。公司在香港联交所场内回购H股共150,000股，占当日已发行股本约0.0445%。回购价格介乎每股23.66港元至24.10港元，合计支付约3,587,840港元（约358.78万港元）。\n本次回购完成后，公司已发行股本变动为328,896,113股，库藏股数增至7,454,631股。回购授权由公司于2025年5月30日获批，授权总数为31,958,111股。公司确认已遵守香港联合交易所有限公司证券上市规则及相关法律规定。\n本公告由公司董事赵中签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02190"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622847243","title":"归创通桥(02190)3月27日斥资358.78万港元回购15万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2622847243","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622847243?lang=zh_cn&edition=full","pubTime":"2026-03-27 18:05","pubTimestamp":1774605946,"startTime":"0","endTime":"0","summary":"智通财经APP讯，归创通桥(02190)发布公告，于2026年3月27日斥资358.78万港元回购15万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1420545.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1587","BK1583","BK1100","02190","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115675300","title":"归创通桥回购10万股股份，耗资约238.37万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1115675300","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115675300?lang=zh_cn&edition=full","pubTime":"2026-03-26 17:32","pubTimestamp":1774517546,"startTime":"0","endTime":"0","summary":"归创通桥医疗科技股份有限公司于2026年3月26日公告，已于香港联交所场内回购10万股H股，占回购前公司已发行股本约0.0297%。每股回购价介乎港币23.56元至24.52元，总金额约238.37万港元。回购完成后，公司已发行股份数为329,046,113股，库藏股数增至7,304,631股，总发行股本仍为336,350,744股。此次回购依据2025年5月30日通过的购回授权进行，授权余量尚可回购31,958,111股，截至目前合计已回购4,485,000股。公司确认已遵守香港联交所上市规则及相关法例，本公告由公司董事赵中签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02190"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622818008","title":"【券商聚焦】中信建投：医疗器械板块拐点来临，26年业绩改善个股存在业绩估值修复机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2622818008","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622818008?lang=zh_cn&edition=full","pubTime":"2026-03-26 09:18","pubTimestamp":1774487918,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投表示，医疗器械板块拐点来临，26年业绩改善个股存在业绩估值修复机会。建议持续关注市场空间大、国产化率低的创新器械赛道，以及并购重组、脑机接口、AI医疗、手术机器人、外骨骼机器人等主题方向的投资机会。潜在催化较多的方向有望出现涨幅数倍的个股，未来AI医疗、脑机接口等也有望成为投资人重点关注的新科技方向。","market":"fut","thumbnail":"https://static.szfiu.com/news/20241108/MjAwMmJhMzhlMzU2ODgyNzA0NzY4MTcyNA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MjAwMmJhMzhlMzU2ODgyNzA0NzY4MTcyNA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1977292","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1571","BK1501","BK1515","02190","BK1584","LU0173614495.USD","01302","LU0287142896.SGD","09997","BK1189","BK1591","BK1100","02235","BK1585","BK1587","BK1247","BK1610","01066","BK1600","BK1617","BK1593","09996","00853","BK1142","BK1583","BK1222","00241","BK1589","BK1161","BK1615","06826","BK0276","601066","BK1502","02252","159883","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160161633","title":"归创通桥回购7.9万股股份，耗资约189.24万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1160161633","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1160161633?lang=zh_cn&edition=full","pubTime":"2026-03-25 19:36","pubTimestamp":1774438585,"startTime":"0","endTime":"0","summary":"归创通桥医疗科技股份有限公司（02190）于2026年3月25日发布公告，披露当日于香港联交所场内回购普通股7.9万股，占该公司已发行股本约0.0234%。\n公司本次回购每股价格介乎23.56港元至24.1港元，合计支付约1,892,410港元。回购完成后，公司已发行股本为329,146,113股，库藏股数增至7,204,631股。\n公告显示，本次回购根据2025年5月30日通过的购回授权进行，授权总数为31,958,111股，截至目前累计已回购4,385,000股。公司确认所有程序符合法律及香港联交所上市规则的规定。\n本公告由公司董事赵中签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02190"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622078523","title":"归创通桥(02190)3月25日耗资约189.24万港元回购7.9万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2622078523","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622078523?lang=zh_cn&edition=full","pubTime":"2026-03-25 19:34","pubTimestamp":1774438449,"startTime":"0","endTime":"0","summary":"智通财经APP讯，归创通桥(02190)公布，2026年3月25日耗资约189.24万港元回购7.9万股股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1418913.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1100","BK1587","02190","BK1574","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149549172","title":"归创通桥3月24日回购2.85万股，耗资约66.56万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1149549172","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1149549172?lang=zh_cn&edition=full","pubTime":"2026-03-24 19:41","pubTimestamp":1774352516,"startTime":"0","endTime":"0","summary":"归创通桥医疗科技股份有限公司(02190)于2026年3月24日公告，当日于香港联交所场内回购股份2.85万股，占当日已发行股本约0.0085%，每股回购价介乎港币22.86元至23.50元，总计耗资约66.56万港元。回购后，公司已发行股本由329,253,613股降至329,225,113股，库藏股数则增至7,125,631股。\n根据公告，公司取得的回购授权通过日期为2025年5月30日，可回购股份总数为31,958,111股，此前已累计回购4,306,000股。本次操作遵守香港联交所相关上市规则及 applicable 法律规定。\n公告由公司董事赵中签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02190"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125090786","title":"归创通桥回购15万股股份，总额约340.51万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1125090786","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1125090786?lang=zh_cn&edition=full","pubTime":"2026-03-23 20:15","pubTimestamp":1774268144,"startTime":"0","endTime":"0","summary":"归创通桥医疗科技股份有限公司(股票代码：02190)于2026年3月23日公告，该公司在香港联交所场内回购15万股H股股份，占当日已发行股本约0.0445%。每股回购价介乎港币22.24港元至23.16港元，总涉资约340.51万港元。\n本次回购完成后，公司已发行股本为329,253,613股，库藏股数量增至7,097,131股。据公告显示，公司回购授权于2025年5月30日获通过，可回购的股份总数为31,958,111股，目前已累计回购4,277,500股。\n公司同时确认，此次回购行为已获得董事会正式授权，并遵守所有适用的上市规则及相关法规。公告由公司董事赵中签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"0db00a063ed3038ffe3988ce052bb688","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02190"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621031977","title":"归创通桥(02190)3月23日斥资340.51万港元回购15万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2621031977","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621031977?lang=zh_cn&edition=full","pubTime":"2026-03-23 20:14","pubTimestamp":1774268044,"startTime":"0","endTime":"0","summary":"智通财经APP讯，归创通桥(02190)发布公告，于2026年3月23日，该公司斥资340.51万港元回购15万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1417575.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1100","BK1587","BK1574","02190"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187790465","title":"归创通桥（02190）回购1,000股股份，总额约2.2万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1187790465","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187790465?lang=zh_cn&edition=full","pubTime":"2026-03-19 18:36","pubTimestamp":1773916579,"startTime":"0","endTime":"0","summary":"归创通桥医疗科技股份有限公司于2026年3月19日更新翌日披露报表，公告显示公司在当天于香港联交所场内回购1,000股H股，占回购前已发行股本约0.0003%。此次回购每股价格为22港元，合计涉资约22,000港元。授权范围内可回购股份数为31,958,111股，截至目前公司已在香港联交所及其他交易所合计回购4,127,500股，约占授权通过当日已发行股本的1.2611%。公司确认，本次交易及相关程序符合香港联交所上市规则及相关法规要求。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02190"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620258306","title":"归创通桥(02190.HK)3月18日耗资218万港元回购10万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2620258306","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620258306?lang=zh_cn&edition=full","pubTime":"2026-03-18 19:37","pubTimestamp":1773833822,"startTime":"0","endTime":"0","summary":"格隆汇3月18日丨归创通桥(02190.HK)发布公告，3月18日耗资218万港元回购10万股，回购价格每股21.26-22.18港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260318/32078901.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1587","BK1574","02190","BK1100","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137289092","title":"归创通桥(02190)回购10万股股份，总额约218.24万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1137289092","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137289092?lang=zh_cn&edition=full","pubTime":"2026-03-18 19:22","pubTimestamp":1773832937,"startTime":"0","endTime":"0","summary":"归创通桥医疗科技股份有限公司于2026年3月18日刊发翌日披露报表，披露当日于香港联交所场内回购股份10万股，占该次回购前已发行股份总数的约0.0296%。本次回购的每股价格介乎港币21.26元至22.18元，总金额约218.24万港元。回购完成后，公司已发行股份为329,404,613股，库藏股数增至6,946,131股。截至目前，公司可回购股份数量为31,958,111股，已回购股份累计4,126,500股，占授权时已发行股份总数约1.2608%。公司确认已遵守香港联交所的上市规则及相关法规。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02190"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620280115","title":"港股异动 | 归创通桥(02190)午后涨超6% 全年纯利增超1.4倍 公司进一步收购德国Optimed股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2620280115","media":"智通财经","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620280115?lang=zh_cn&edition=full","pubTime":"2026-03-18 15:16","pubTimestamp":1773818194,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，归创通桥午后涨超6%，截至发稿，涨5.17%，报21.96港元，成交额1489.67万港元。消息面上，归创通桥发布年度业绩，全年营业收入10.57亿元人民币，同比增长35.1%；净利润突破2.44亿元人民币，同比大幅增长143.7%。此外，归创通桥公布行使期权，收购Optimed Holding 11%股权，并于2028年上半年收购余下40%股权至全资拥有，总代价估计最高4,117万欧元。资料显示，Opitmed是一家德国医疗科技企业，专注于微创血管介入及泌尿介入医疗器械的研发、生产与全球销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1415359.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1587","BK1574","FDAXmain","BK1583","VXUS","BK4585","FDXMmain","FDXSmain","02190","BK4588","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119616244","title":"异动解读 | 归创通桥发布强劲2025年业绩，盘中大涨5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=1119616244","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1119616244?lang=zh_cn&edition=full","pubTime":"2026-03-18 14:19","pubTimestamp":1773814768,"startTime":"0","endTime":"0","summary":"归创通桥今日盘中股价大幅上涨5.27%，引起了市场的广泛关注。消息面上，公司发布了2025年度强劲的财务业绩报告，是推动股价上涨的主要因素。报告显示，公司2025年实现营业收入10.57亿元，同比增长35.1%；净利润大幅增长143.7%，达到2.44亿元。同时，海外业务表现尤为亮眼，收入同比增长高达115.5%，产品已进入全球80多个国家和地区。此外，公司全年毛利率维持在72.1%的高水平，销售费用率有所下降，现金流充裕。董事会已提议派发末期股息，这些积极的财务指标增强了投资者对公司未来增长前景的信心，从而推动了股价的上涨。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02190"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160372204","title":"归创通桥2025年业绩亮眼：营收突破10.6亿元，净利润同比飙升143.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1160372204","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1160372204?lang=zh_cn&edition=full","pubTime":"2026-03-18 00:20","pubTimestamp":1773764418,"startTime":"0","endTime":"0","summary":"归创通桥（股票代码：02190）近日公布了其2025年度财务报告，业绩表现十分抢眼。公司全年营收成功突破10.6亿元人民币大关，展现出强劲的增长势头。\n更值得关注的是，其净利润实现了惊人的同比增长，增幅高达143.7%，盈利能力得到显著提升。这一亮眼成绩单，充分反映了公司在市场拓展和运营效率方面的卓越表现。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","BK1574","02190","BK1100","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160558775","title":"归创通桥（02190）行使期权增持德企股权至60%，总对价最高3.26亿元并承诺2028年再购40%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=1160558775","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1160558775?lang=zh_cn&edition=full","pubTime":"2026-03-17 21:52","pubTimestamp":1773755540,"startTime":"0","endTime":"0","summary":"3月17日，归创通桥医疗科技股份有限公司发布公告称，已向E-Med Solutions发出行使通知，拟以最高0.41亿元人民币收购目标公司11%股权，并于2028年上半年继续收购剩余40%股权，对价上限2.85亿元人民币。连同此前已完成的49%股权交易，归创通桥在本轮交割完成后将持有目标公司60%股权，目标公司将并表成为其子公司。整体来看，本次期权及后续收购的总对价最高达3.26亿元人民币。截至2025年末，公司总资产约2.21亿元人民币，净资产约1.02亿元人民币。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02190"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620842471","title":"归创通桥：2025年溢利同比增长143.7%至2.44亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2620842471","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620842471?lang=zh_cn&edition=full","pubTime":"2026-03-17 20:26","pubTimestamp":1773750419,"startTime":"0","endTime":"0","summary":"3月17日，归创通桥（02190）发布截至2025年12月31日止年度的年度业绩公告。公司实现收入10.57亿元，同比增长35.1%；毛利为7.63亿元，毛利率为72.1%。年内溢利为2.44亿元，同比大幅增长143.7%。年内非《国际财务报告准则》经调整溢利净额为2.73亿元，增长120.2%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603173674804066.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1587","BK1583","BK1100","02190","BK1574"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.zyloxmedical.com","stockEarnings":[{"period":"1week","weight":-0.0194},{"period":"1month","weight":0.0661},{"period":"3month","weight":0.0061},{"period":"6month","weight":-0.0561},{"period":"1year","weight":0.4663},{"period":"ytd","weight":0.0061}],"compareEarnings":[{"period":"1week","weight":-0.011},{"period":"1month","weight":-0.0692},{"period":"3month","weight":-0.0329},{"period":"6month","weight":-0.0916},{"period":"1year","weight":0.0722},{"period":"ytd","weight":-0.0329}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"归创通桥医疗科技股份有限公司是一家主要从事为患者及医生提供涵盖神经血管介入器械及外周血管介入器械的产品组合解决方案的中国公司。神经血管介入产品主要包括“银蛇”颅内支持导管、“凤”颅内动脉瘤栓塞弹簧圈、“通桥麒麟”血流导向装置、“蛟龙”取栓支架以及“北斗SS”神经血管导丝等。外周血管介入产品主要包括“UltraFree”药物洗脱经皮腔内血管成形术（PTA）球囊扩张导管、“ZYLOX Octoplus”可回收腔静脉滤器、腔静脉滤器抓捕器及“ZYLOX Swan”静脉腔内射频闭合导管等。该公司主要在中国国内市场及德国、法国、意大利、土耳其等海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.038267},{"month":2,"riseRate":0.4,"avgChangeRate":-0.097164},{"month":3,"riseRate":0.6,"avgChangeRate":0.021512},{"month":4,"riseRate":0.75,"avgChangeRate":0.111063},{"month":5,"riseRate":0.5,"avgChangeRate":-0.029077},{"month":6,"riseRate":0.75,"avgChangeRate":0.088544},{"month":7,"riseRate":0.5,"avgChangeRate":-0.038763},{"month":8,"riseRate":0.4,"avgChangeRate":-0.049708},{"month":9,"riseRate":0.6,"avgChangeRate":0.019857},{"month":10,"riseRate":0.2,"avgChangeRate":-0.028854},{"month":11,"riseRate":0.6,"avgChangeRate":0.041084},{"month":12,"riseRate":0.6,"avgChangeRate":0.027438}],"exchange":"SEHK","name":"归创通桥","nameEN":"ZYLOXTB"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"归创通桥(02190)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供归创通桥(02190)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"归创通桥,02190,归创通桥股票,归创通桥股票老虎,归创通桥股票老虎国际,归创通桥行情,归创通桥股票行情,归创通桥股价,归创通桥股市,归创通桥股票价格,归创通桥股票交易,归创通桥股票购买,归创通桥股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"归创通桥(02190)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供归创通桥(02190)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}